Search results for "lipid"

showing 10 items of 3879 documents

Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content

2011

Piqueras M, Navarro S, Canete A, Castel V & Noguera R (2011) Histopathology59, 22–30 Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content Aims:  Better understanding of neuroblastoma genetics will improve with genome-wide techniques. However, performing these analyses in samples with <60% neuroblast cells is not adequate. We evaluated the utility of fluorescence in situ hybridization (FISH) on tissue microarrays (TMA) in detecting partial genetic instability (PGI), focusing on samples with ≤50% neuroblast cells. Methods and results:  Alterations of 11q and 17q were detected by FISH on 369 neuroblastoma samples in TMA. Status of the MYCN gene a…

medicine.medical_specialtyPathologyHistologyTissue microarraymedicine.diagnostic_testCellCancerAnatomical pathologyGeneral MedicineBiologymedicine.diseasePathology and Forensic Medicinemedicine.anatomical_structureNeuroblastGenetic markerNeuroblastomamedicinelipids (amino acids peptides and proteins)Fluorescence in situ hybridizationHistopathology
researchProduct

Oral capecitabine and Vinorelbine in Metastatic Breast Cancer. A Retrospective Analysis of Tolerability and Activity

2012

ABSTRACT Background The purpose of this study was to retrospectively analyze toxicity profile and activity of an all-oral combination schedule of Capecitabine (Cape) and Vinorelbine (VNR) in metastatic breast cancer (MBC) patients (pts). Methods All pts treated had a histological confirmed diagnosis of breast cancer (BC). Each 3-week cycle of treatment consisted of 500 mg/m2 cape twice daily (2 weeks on, 1 week off), and 60 mg/m2 VNR on days 1 and 8. Results From June'07 to December'11 we analyzed 77 MBC pts. Median age was 52 years (range 34-73). 58 pts (75,3%) had a performance status (PS) ECOG 0; 13 pts (16,8%) PS1, 6 pts (7,8%) PS2. 5 pts (6,5%) had metastatic disease at time of diagnos…

medicine.medical_specialtyPerformance statusbusiness.industrymacromolecular substancesHematologyNeutropeniamedicine.diseaseVinorelbineMetastatic breast cancerGastroenterologycarbohydrates (lipids)Capecitabinestomatognathic diseasesRegimenBreast cancerOncologyInternal medicineotorhinolaryngologic diseasesmedicinebacteriaProgression-free survivalbusinessmedicine.drugAnnals of Oncology
researchProduct

SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE

2014

High-density lipoproteins (HDL) are classified as atheroprotective because they are involved in transport of cholesterol to the liver, known as "reverse cholesterol transport (RCT)" exerting antioxidant and anti-inflammatory activities. There is also evidence for cytoprotective, vasodilatory, antithrombotic, and anti-infectious activities for these lipoproteins. HDLs are known by structural, metabolic and biologic heterogeneity. Thus, different methods are able to distinguish several subclasses of HDL. Different separation techniques appear to support different HDL fractions as being atheroprotective or related with lower cardiovascular (CV) risk. However, HDL particles are not always prote…

medicine.medical_specialtyPharmacologyBiologySystemic inflammationBiochemistrychemistry.chemical_compoundRisk FactorsInternal medicineDrug DiscoveryAntithromboticmedicineAnimalsHumansHdl functionalityPharmacologyCholesterolOrganic ChemistryReverse cholesterol transportBiomarker (cell)EndocrinologychemistryCardiovascular DiseasesMolecular MedicineSeparation methodlipids (amino acids peptides and proteins)Hdl subfractionscardiovascular risk electrophoresis high-density lipoprotein nuclear magnetic resonance proteome subclasses subfractions ultracentrifugation.medicine.symptomLipoproteins HDL
researchProduct

Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregna…

2021

Abstract Myeloproliferative neoplasms (MPN) are traditionally regarded as a disease of older adults, though a not negligible fraction of cases occurs at a younger age, including women of childbearing potential. MPN in younger patients, indeed, offer several challenges for the clinical hematologist, that goes from difficulties in reaching a timely and accurate diagnosis to a peculiar thrombotic risk, with a relatively high incidence of thromboses in unusual sites (as the splanchnic veins or the cerebral ones). Moreover, the issue of pregnancy is recently gaining more attention as maternal age is rising and molecular screening are widely implemented, leading to a better recognition of these c…

medicine.medical_specialtyPhiladelphia Chromosome NegativeMyeloproliferative neoplasmDiseaseEssential thrombocythemiaCritical discussionMyeloproliferative neoplasmsAntiphospholipid syndromePregnancyNeoplasmsmedicineHumansPhiladelphia ChromosomeHematologistIntensive care medicineAgedEssential thrombocythemia; Myeloproliferative neoplasms; PregnancyPregnancyMyeloproliferative DisordersEssential thrombocythemiabusiness.industryIncidencefood and beveragesThrombosisHematologymedicine.diseaseOncologyYounger adultsFemalebusinessmanagement
researchProduct

Breakdown of choline-containing phospholipids in rat brain during severe weight loss.

2002

Recent investigations in human anorectic patients indicated changes of brain choline metabolism. We used starved rats to investigate possible changes of brain choline metabolites during severe weight loss. Reductions of body weight by 15, 30 and 45% resulted in significant decreases of cerebral phosphatidylcholine and sphingomyelin levels. Concomitantly, the brain tissue content of glycerophosphocholine was increased while phosphocholine and free choline were unchanged. We conclude that severe weight loss is accompanied by phospholipase activation and breakdown of choline-containing phospholipids in the brain.

medicine.medical_specialtyPhospholipidPhospholipaseBiologyCholinechemistry.chemical_compoundWeight lossInternal medicinePhosphatidylcholineWeight LossmedicineCholineAnimalsRats WistarPhospholipidsPhosphocholineGeneral NeuroscienceBrainNutrition DisordersRatsEndocrinologychemistryAnorecticFemalemedicine.symptomSphingomyelinNeuroscience letters
researchProduct

Rheological and metabolic leucocyte determinants in diabetes mellitus

1995

In diabetics of type I and 2 we examined, in resting white blood cells (WBC), the filtration parameters (Initial Relative Flow Rate - lRFR, Clogging Rate - CR) employing the St. George Filtrometer, the polymorphonuclear cells (PMN) membrane fluidity, the PMN cytosolic Ca2+ content and the PMN membrane cholesterol/phospholipid ratio (C/PL). From the obtained data, it is evident that, while the lRFR of unfractionated WBC distinguishes normals from diabetics of type 1 and 2, the fIltration parameters of the PMN and mononuclear cells (MN) do not show any significant difference. PMN membrane fluidity, PMN cytosolic Ca2+ content and PMN C/PL do not discriminate normals from diabetics of type 1 an…

medicine.medical_specialtyPhysiologyCholesterolPhospholipidhemic and immune systemsHematologyMetabolismGranulocytemedicine.diseasePeripheral blood mononuclear cellchemistry.chemical_compoundCytosolmedicine.anatomical_structureEndocrinologychemistryPhysiology (medical)Internal medicineDiabetes mellitusmedicineMembrane fluidityCardiology and Cardiovascular MedicineClinical Hemorheology and Microcirculation
researchProduct

Lipid peroxidation capacities in the myocardium of endurance-trained rats and mice in vitro.

1992

The endurance-training programme in Experiment 1 (Exp. 1) consisted of a total swimming time of 149–159 h per male Han Wistar rat and in Experiment 2 (Exp. 2) the male NMRI-mice run on a treadmill at a speed of 25 m min-1 1 h per day, 5 days a week for 3 weeks. One group of the rat hearts was perfused with 0.3 mm cumene hydroperoxide (CumOOH) while the others were fractioned (mitochondria, sarcolemma and sarcoplasmic reticulum) and these cell fractions and homogenates were used to determine the total concentration of peroxidative lipids and the susceptibility to lipid peroxidation. The perfusion with CumOOH caused the release of thiobarbituric acid reactive substances (TBARS) into the perfu…

medicine.medical_specialtyPhysiologyThiobarbituric acidThiobarbituric Acid Reactive SubstancesMitochondria HeartRunningLipid peroxidationchemistry.chemical_compoundMiceSarcolemmaEndurance trainingInternal medicinePhysical Conditioning AnimalmedicineTBARSAnimalsRats WistarCreatine KinaseSwimmingSarcolemmaChemistryMyocardiumGlutathioneGlutathioneRatsPerfusionSarcoplasmic ReticulumEndocrinologyBiochemistryCumene hydroperoxideLipid PeroxidationPerfusionSubcellular FractionsActa physiologica Scandinavica
researchProduct

Platelet membrane fluidity, platelet membrane lipid pattern and platelet cytosolic Ca2+ content in subjects with vascular atherosclerotic disease

1994

In a group of subjects with vascular atherosclerotic disease (V AD) we examined the platelet membrane fluidity (obtained marking intact resting platelets with TMA-DPH), the platelet membrane cholesteroVphospholipid ratio (CIPL using column chromatography), the platelet membrane individual phospholipids (employing the thin layer chromatography) and the platelet cytosolic Ca2+ content (evaluated marking intact resting platelets with Fura 2-AM). From the obtained data, it is evident that platelet membrane fluidity differentiates normals from V AD subjects. Platelet membrane lipid pattern (CIPL and individual phospholipids) and cytosolic Ca2+ content do not discriminate normals from V AD subjec…

medicine.medical_specialtyPhysiologyVascular diseaseHematologyPhosphatidylserineBiologymedicine.diseasePLATELET MEMBRANE FLUIDITYCytosolchemistry.chemical_compoundEndocrinologyColumn chromatographyMembranechemistryPhysiology (medical)PhosphatidylcholineInternal medicinemedicinelipids (amino acids peptides and proteins)PlateletCardiology and Cardiovascular MedicineClinical Hemorheology and Microcirculation
researchProduct

The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice

2009

Oleoylethanolamide (OEA) is an endogenous lipid produced in the intestine that mediates satiety by activation of peroxisome proliferator-activated receptor alpha (PPARalpha). OEA inhibits gastric emptying and intestinal motility, but the mechanism of action remains to be determined. We investigated whether OEA inhibits intestinal motility by activation of PPARalpha. PPARalpha immunoreactivity was examined in whole mount preparations of mouse gastrointestinal (GI) tract. The effect of OEA on motility was assessed in wildtype, PPARalpha, cannabinoid CB(1) receptor and CB(2) receptor gene-deficient mice and in a model of accelerated GI transit. In addition, the effect of OEA on motility was as…

medicine.medical_specialtyPhysiologymedicine.medical_treatmentTRPV Cation ChannelsMotilityOleic AcidsBiologydigestive systemReceptor Cannabinoid CB2MiceOleoylethanolamidechemistry.chemical_compoundReceptor Cannabinoid CB1Glucagon-Like Peptide 1Internal medicinemedicineAnimalsPPAR alphaReceptorMice KnockoutGastric emptyingEndocrine and Autonomic Systemsdigestive oral and skin physiologyGastroenterologyImmunohistochemistryEndocannabinoid systemEndocrinologyMechanism of actionchemistrylipids (amino acids peptides and proteins)CannabinoidPeroxisome proliferator-activated receptor alphamedicine.symptomGastrointestinal MotilityEndocannabinoids
researchProduct

Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial.

2011

Crataegus laevigata is a medicinal plant most commonly used for the treatment of heart failure and psychosomatic disorders. Based on previous experimental findings, this double-blind placebo-controlled study was aimed at finding beneficial effects of C. laevigata on biomarkers of coronary heart disease (CHD). The study included 49 diabetic subjects with chronic CHD who were randomly assigned to the treatment for 6 months with either a micronized flower and leaf preparation of C. laevigata (400 mg three times a day) or a matching placebo. Blood cell count, lipid profile, C-reactive protein, neutrophil elastase (NE) and malondialdehyde were analyzed in plasma at baseline, at one month and six…

medicine.medical_specialtyPlacebo-controlled studyPharmaceutical ScienceCoronary DiseaseFlowersPlaceboGastroenterologyDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodInterquartile rangeInternal medicineDiabetes mellitusDrug DiscoverymedicineHumansAgedPharmacologyCrataegusmedicine.diagnostic_testbiologybusiness.industryCholesterolPlant ExtractsC-reactive proteinCholesterol LDLMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryCrataegus laevigataPlant LeavesC-Reactive ProteinComplementary and alternative medicinechemistryDiabetes Mellitus Type 2biology.proteinMolecular MedicineLipid PeroxidationLipid profilebusinessLeukocyte ElastasePhytotherapyPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct